Dr. Uddin earned a BS. and MS. in Biochemistry and Molecular Biology from University of Dhaka, Bangladesh. He then earned his PhD. in Molecular Medicine from Gifu University, Japan. Dr. Uddin was awarded Japanese Society for Promotion of Science (JSPS) postdoctoral fellowship (2003 -2005). Dr. Uddin is also a Fellow of the American Heart Association and is also serving as a Councilor of the Central Society for Clinical and Translational Research (CSCTR) for 2017-2020. He has published more than 100 peer-reviewed articles and has presented more than 200 abstracts in national and international meetings. Dr. Uddin has also mentored more than 100 medical students, medical residents and fellows, graduate students, and postdoctoral fellows. He is a member of several professional societies and also is a peer review member of several journals and funding agencies in the United States and several other countries.

​

Dr. Afroze earned a BS. and MS. in Biology, with a minor in Biochemistry, from the University of Dhaka, Bangladesh. Subsequently, she obtained her PhD. in Microbial Biotechnology from Gifu University, Japan. Since moving from Japan with her family, Dr. Afroze has been working as a research associate at the Texas A&M Health Science Center College of Medicine. Here Dr. Afroze has made significant advances in the field of ovarian cancer with her studies into cinobufotalin-induced cellular mechanisms of ovarian cancer cell function. Her research findings have provided avenues in how to design the CINO-induced, therapeutic intervention of ovarian cancer. Additionally, Dr. Afroze has written numerous articles in high-impact, peer-reviewed journals and has presented a number of abstracts at national and international meetings.

CURRENT POSITIONS

Visiting scientist, Department of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine & Research, The University of Texas M.D. Anderson Cancer Center, Bastrop, Texas 
(July, 2019 to present)
Statistics consultant, Living Well Aware, a wellness enterprise with Dr. Patricia Sulak as president, Temple, Texas (August, 2019 to present) Statistics and experimental design consultant, Emergent Biotechnologies, LLC, Temple, Texas 
(July, 2019 to present) 
Statistics consultant for pelvic floor studies with group of investigators at East Tennessee State University, Johnson City, Tennessee
(July, 2020 to present)

​

RETIRED POSITIONS

(June 30, 2019): Mary Jane Noble Centennial Endowed Chair of Research in Obstetrics & Gynecology, Baylor Scott & White Health, Temple, Texas 
Professor, Texas A&M Health Science Center College of Medicine, Temple, Texas
Scientific Director, Division of Research, Department of Obstetrics & Gynecology, Baylor Scott & White Health, Temple, Texas
Embryologist and Embryology Laboratory Director,
Division of Reproductive Endocrinology & Infertility, Department of Obstetrics & Gynecology, Scott & White Medical Center, Temple, Texas
Chief, Section of Andrology, Department of Pathology, Baylor Scott & White Health
Adjunct Professor, Department of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine & Research, The University of Texas M.D. Anderson Cancer Center, Bastrop, Texas

​

PROFESSIONAL EDUCATION: Michigan State University, East Lansing, Michigan
Year Degree Major area
1972 B.S. (Honors) Physiology
1974 M.S. Reproductive physiology
1976 Ph.D. Reproductive physiology & biochemistry

​

Other Postgraduate Education:
1991 Completed molecular biology laboratory training in recombinant DNA techniques at New England Biolabs Workshop in Molecular Biology & Biotechnology, June 2-15, Smith College, Northampton, MA.
1995 Completed hands-on workshop of techniques for micromanipulation in assisted reproduction including tool making, intracellular sperm injection, and blastomere biopsy, May 13-16. Program part of series: Challenges Toward the Year 2000 sponsored by the University of Nevada School of Medicine, Las Vegas, NV.
1997 Completed hands-on workshop of techniques for micromanipulation in assisted including tool making and intracellular sperm injection, March 12-14, Jones
Institute, Norfolk, VA.
2011 Completed hands-on workshop for vitrification of mature ova prior the Second International Congress for Fertility Preservation, December 7, Miami, FL, with follow-up training on Nonhuman primate follicle collection and culture, and ovarian cortex vitrification in Dr. Mary Zelinsky’ lab which served as component of NIH-sponsored Oncofertility Consortium, Jan 4-5, Oregon National Primate Research Center, Beaverton, OR.

​

​

John brings to the Artemis Institute over 30 years experience working with multidisciplinary teams to apply the tools of biology, chemistry, and physics to biological and medical problems. While at Johns Hopkins, he had the honor of working for a time in the laboratories of the late Dr. Philip E. Hartman, where he became proficient in classical bacterial genetics and standard microbiological techniques, and Dr. Ludwig Brand, where he learned the power of fluorescence technologies to probe the structures, interactions, and conformational dynamics of proteins. Since then, he has developed and applied instrumental methods for the analysis of biomolecules, including electrochemiluminescence, real-time, immunoassay, and capillary electrophoresis methods for the analysis of nucleic acids. He has developed a number of PCR-based assays, for infectious agents and human genetic diseases, and is familiar with methods for long-range PCR, PCR of low-copy and difficult targets, and extremely broad-range PCR, which he has applied to novel virus discovery. He has applied HPLC to the analysis of small molecules and proteins and has developed ion-exchange methods for nucleic acid analysis by HPLC. John has worked for a number of small and medium-sized companies in the life sciences, including AntiVirals, Inc. (now Sarepta Therapeutics) where he established the first diagnostics program to explore the potential of novel antisense morpholino oligos for sequence-specific recognition of RNA and DNA targets. At Genelabs Technologies, he contributed his PCR expertise as part of the team that identified a previously unknown human hepatitis virus. At Applied Biosystems, he developed the first PCR test for fragile X syndrome, which can reliably amplify up to 2,000 CGG repeats. In addition, he has co-founded a number of companies, including Lucidant Polymers (www.lucidant.com; polyacrylamide copolymers for capillary electrophoresis and microarray analysis), CytoMag (www.cytomag.com; rare cell analysis using novel magnetic sifter technology licensed from Stanford), Sophoro Biotechnologies (discovered new-to-nature sophorose analog for high-efficiency induction of gene expression in T. reesei), and others.

​

Md. Kamruzzaman is a seasoned professional with over nine years of extensive experience in the pharmaceutical industry. With a Bachelor of Science in Pharmacy from Stamford University, Dhaka, Kamruzzaman has honed expertise in pharmaceutical business development, specializing in Pharma API, particularly in Oncology products. He has been serving as the Managing Director at multiple ventures including Future Chemicals Ltd., Dawn Pharmaceutical Ltd., Round Care Bangladesh Ltd., and Future Cosmetics & Healthcare Ltd., Kamruzzaman has exhibited exceptional leadership in steering these organizations toward success. Additionally, his role as a Business Development Consultant for Drug International Limited, focusing on the Chinese market, showcases his diverse expertise. His proficiency extends to pharmaceutical products export, reflecting a comprehensive skill set and a dynamic career dedicated to advancing the pharmaceutical landscape.

As an Outreach Director, Ahmed is dedicated to bringing people together and fostering strong community connections. With a background in community organizing and outreach, He has honed his skills in engaging diverse groups of individuals to work towards a common goal.

His professional experience includes leading successful outreach campaigns that have raised awareness of important issues and mobilized individuals to take action. Ahmed is passionate about creating opportunities for people to come together and build meaningful relationships, and he has a track record of developing effective strategies to reach diverse audiences.

In addition to his outreach experience, Ahmed is an excellent communicator with strong interpersonal skills. He is comfortable engaging with individuals from all backgrounds and has a talent for building relationships with stakeholders at all levels.

​

As a Medical Director, Dr. Shaili oversees the clinical operations of a large hospital system, where she works closely with other healthcare leaders to develop and implement strategic plans. She also collaborates with physicians and other healthcare providers to improve patient care and outcomes, and monitors data to identify areas for improvement.

As the Director of Business Development and IT, Syed has extensive experience in both technology and business strategy. He possesses a strong technical background coupled with exceptional business acumen, enabling to identify and capitalize on opportunities that drive revenue growth and operational excellence.

Throughout Syed's career, he has demonstrated a proven track record of success in establishing long-term partnerships with clients, enhancing brand awareness, and achieving business objectives. HIs expertise in developing and executing comprehensive sales strategies, managing complex projects, and leading cross-functional teams has resulted in consistently exceeding business targets.

In addition to his technical and business qualifications, He holds a bachelor's degree in computer science. Syed is passionate about leveraging cutting-edge technologies and innovative solutions to drive business growth and create new revenue streams.